BeOne Medicines Ltd.
ONCAs of the close on Sep 25, 2026
Price
$360.85
Market cap
$533B
P/E (diluted TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
EPS (TTM)
—
The fourth quarter's per-share figure could not be confirmed from the annual report
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How BeOne Medicines Ltd. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 12 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 25, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| HARBOUR INVESTMENTS, INC. | 2026-03-31 | 42 | Not shown | SEC filing |
| Sanctuary Advisors, LLC | 2026-03-31 | 2,982 | Not shown | SEC filing |
| Acumen Wealth Advisors, LLC | 2026-03-31 | 16 | Not shown | SEC filing |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 2026-03-31 | 126 | Not shown | SEC filing |
| Quantinno Capital Management LP | 2026-03-31 | 8,312 | Not shown | SEC filing |
| TIAA-CREF INDIVIDUAL & INSTITUTIONAL SERVICES, LLC | 2026-03-31 | 4,439 | Not shown | SEC filing |
| Blue Trust, Inc. | 2026-03-31 | 826 | Not shown | SEC filing |
| MAI Capital Management | 2026-03-31 | 43 | Not shown | SEC filing |
| TD Asset Management Inc | 2026-03-31 | 10,014 | Not shown | SEC filing |
| Knollwood Investment Advisory, LLC | 2026-03-31 | 1,111 | Not shown | SEC filing |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 2026-03-31 | 14,808 | Not shown | SEC filing |
| Verition Fund Management LLC | 2026-03-31 | 882 | Not shown | SEC filing |
| True Light Capital Pte. Ltd. | 2026-03-31 | 3,480 | Not shown | SEC filing |
| CIBC WORLD MARKET INC. | 2026-03-31 | 805 | Not shown | SEC filing |
| Versant Capital Management, Inc | 2026-03-31 | 3 | Not shown | SEC filing |
| Pathstone Holdings, LLC | 2026-03-31 | 1,005 | Not shown | SEC filing |
| Nemes Rush Group LLC | 2026-03-31 | 4 | Not shown | SEC filing |
| Rakuten Securities, Inc. | 2026-03-31 | 7 | Not shown | SEC filing |
| Abound Wealth Management | 2026-03-31 | 1 | Not shown | SEC filing |
| Financial Perspectives, Inc | 2026-03-31 | 588 | Not shown | SEC filing |
- Each value is checked against BeOne Medicines Ltd.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 20 rows: no share price from within three months of their report dates is on file, so they could not be checked.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among BeOne Medicines Ltd.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2025-12-16 · OYLER JOHN: Larger than 124 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-12-15 · OYLER JOHN: Larger than 134 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-12-15 · OYLER JOHN: Larger than 131 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-12-15 · OYLER JOHN: Larger than all 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-09-16 · OYLER JOHN: Larger than 133 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-14 · Wu Xiaobin: Larger than 125 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-14 · Wu Xiaobin: Larger than 122 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-14 · Wu Xiaobin: Larger than 132 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-13 · Wu Xiaobin: Larger than 126 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-13 · Wu Xiaobin: Larger than 128 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-13 · Wu Xiaobin: Larger than 123 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-08-13 · Wu Xiaobin: Larger than 129 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-07-09 · OYLER JOHN: Larger than 127 of the 135 other insider sales of American Depositary Shares on file. SEC filing
- 2025-07-09 · OYLER JOHN: Larger than 130 of the 135 other insider sales of American Depositary Shares on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-23 | Wang Lai · President, Global Head of R&D | American Depositary Shares | S — Open market or private sale | −1,068 | 276.74 | SEC filing |
| 2026-06-23 | Wu Xiaobin · President and COO | American Depositary Shares | S — Open market or private sale | −1,292 | 276.26 | SEC filing |
| 2026-06-23 | OYLER JOHN · Chief Executive Officer | American Depositary Shares | S — Open market or private sale | −1,800 | 273.30 | SEC filing |
| 2026-06-23 | OYLER JOHN · Chief Executive Officer | American Depositary Shares | S — Open market or private sale | −1,290 | 274.12 | SEC filing |
| 2026-06-23 | OYLER JOHN · Chief Executive Officer | American Depositary Shares | S — Open market or private sale | −320 | 275.10 | SEC filing |
| 2026-06-16 | Wu Xiaobin · President and COO | American Depositary Shares | S — Open market or private sale | −1,357 | 266.76 | SEC filing |
| 2026-06-16 | Wang Lai · President, Global Head of R&D | American Depositary Shares | S — Open market or private sale | −1,169 | 265.39 | SEC filing |
| 2026-06-16 | OYLER JOHN · Chief Executive Officer | American Depositary Shares | S — Open market or private sale | −333 | 266.69 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-06-11 | Sawyers Charles Lazelle · Director | Ordinary Shares | A — Grant, award, or other acquisition | +18,980 | SEC filing |
| 2026-06-11 | Mooney Elizabeth Fisher · Director | Ordinary Shares | A — Grant, award, or other acquisition | +18,980 | SEC filing |
| 2026-06-11 | BAKER JULIAN · Director | Ordinary Shares | A — Grant, award, or other acquisition | +18,980 | SEC filing |
| 2026-06-11 | OYLER JOHN · Chief Executive Officer | Ordinary Shares | A — Grant, award, or other acquisition | +177,931 | SEC filing |
| 2026-06-11 | Riva Alessandro · Director | Ordinary Shares | A — Grant, award, or other acquisition | +18,980 | SEC filing |
| 2026-06-11 | Wang Xiaodong · Director, other | Share Option (Right to Buy) | A — Grant, award, or other acquisition | +193,492 | SEC filing |
| 2026-06-11 | Wang Xiaodong · Director, other | Ordinary Shares | A — Grant, award, or other acquisition | +99,892 | SEC filing |
| 2026-06-11 | HOOPER ANTHONY C · Director | Ordinary Shares | A — Grant, award, or other acquisition | +18,980 | SEC filing |
Showing 8 of 24 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.